Hereditary prostate cancer: genes related, target therapy and prevention

MT Vietri, G D'Elia, G Caliendo, M Resse… - International journal of …, 2021 - mdpi.com
Prostate cancer (PCa) is globally the second most diagnosed cancer type and the most
common cause of cancer-related deaths in men. Family history of PCa, hereditary breast …

Data mining in healthcare: Applying strategic intelligence techniques to depict 25 years of research development

ML Kolling, LB Furstenau, MK Sott, B Rabaioli… - International journal of …, 2021 - mdpi.com
In order to identify the strategic topics and the thematic evolution structure of data mining
applied to healthcare, in this paper, a bibliometric performance and network analysis …

Early detection of prostate cancer: AUA/SUO guideline part I: prostate cancer screening

JT Wei, D Barocas, S Carlsson, F Coakley… - Journal of …, 2023 - journals.lww.com
Purpose: The summary presented herein covers recommendations on the early detection of
prostate cancer and provides a framework to facilitate clinical decision-making in the …

[PDF][PDF] 中国前列腺癌筛查与早诊早治指南(2022, 北京).

赫捷, 陈万青, 李霓, 曹巍, 叶定伟, 马建辉… - Chinese Journal of …, 2022 - jhxrmyy.com
前列腺癌是好发于老年男性的生殖系统恶性肿瘤. 前列腺癌高风险人群筛查与患者的早诊早治对
提高前列腺癌治愈率至关重要. 制定符合中国国情的前列腺癌筛查与早诊早治指南 …

Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects

S Ito, X Liu, Y Ishikawa, DD Conti, N Otomo… - Nature …, 2023 - nature.com
Prostate cancer (PrCa) is the second most common cancer worldwide in males. While
strongly warranted, the prediction of mortality risk due to PrCa, especially before its …

Defining the impact of family history on detection of high-grade prostate cancer in a large multi-institutional cohort

MB Clements, EA Vertosick, L Guerrios-Rivera… - European urology, 2022 - Elsevier
Background The risk of high-grade prostate cancer, given a family history of cancer, has
been described in the general population, but not among men selected for prostate biopsy in …

BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype

I Gorodetska, V Lukiyanchuk, C Peitzsch… - … journal of cancer, 2019 - Wiley Online Library
Prostate cancer (PCa) is the second most common malignancy and the sixth leading cause
of cancer‐related death among men worldwide. Prostate carcinogenesis is driven by the …

Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine

F Marino, A Totaro, C Gandi, R Bientinesi… - Prostate Cancer and …, 2023 - nature.com
Background The goal of precision medicine in prostate cancer (PCa) is to individualize the
treatment according to the patient's germline mutation status. PCa has a very high rate of …

[HTML][HTML] Mitochondria dysfunction-mediated molecular subtypes and gene prognostic index for prostate cancer patients undergoing radical prostatectomy or …

D Feng, X Shi, F Zhang, Q Xiong, Q Wei… - Frontiers in …, 2022 - frontiersin.org
Background: Given the age relevance of prostate cancer (PCa) and the role of mitochondrial
dysfunction (MIDS) in aging, we orchestrated molecular subtypes and identified key genes …

The etiology of prostate cancer

KL Ng - Exon Publications, 2021 - exonpublications.com
While the exact etiology of prostate cancer remains elusive, various modifiable and
unmodifiable risk factors have been suggested as contributing factors. These include age …